In ASCVD patients, is LDL <70 mg/dL good enough — or should we push harder to <55?
Ez-PAVE trial (NEJM) delivers a clear answer: intensive targeting cuts major events by 33%.
Practice-changing for secondary prevention?
11
GAME-CHANGER in VTE management just dropped in NEJM.
Apixaban cuts clinically relevant bleeding by >50% compared to rivaroxaban in acute PE/DVT
#Cardiology #VTE #DOAC #Anticoagulation #MedicalEducation #HeartHealth #MedTwitter #CardioTwitter #JACC #NEJM #AHA #ESC
31
FIRST dedicated Acute PE guideline (AHA/ACC 2026) just dropped!
Old: Vague risk → inconsistent escalation.
Categories A–E (shock + RV strain + biomarkers) + early PERT call for intermediate/high-risk.
Blood thinners first; advanced Rx selective → fewer bleeds, more lives saved.
12
🚨 Cardiologists: Old rule = tolerate low-normal K+ in ICD pts to dodge hyperK fears.
New POTCAST reality (NEJM): Push to high-normal (4.5–5.0 mmol/L) → ~31% ↓ in VT/ICD shocks, arrh/HF hosp, or death.
Cheap K+ boost or MRA tweak = big arrhythmia protection.
#Cardiology #EPeeps
34
BREAKING HF STRATEGY UPDATE 📢
A single polypill for HFrEF significantly improved heart function, symptoms, quality of life & cut hospital visits vs separated meds.
#heartfailure #Cardiology #Medicine #pharmacy
13
NEW CARDIOLOGY DISCOVERY
Patients with chest pain and normal coronary angiograms may still have true angina from microvascular disease — detectable with stress cardiac MRI! 🧠
This may change how we approach “normal cath results.”
#Cardiology #Angina #aha #HeartHealth
1
21
🚀 BREAKTHROUGH in Heart Health Tech!
AI + smartwatch ECG can now detect structural heart disease including LV dysfunction, valve damage & hypertrophy from a single-lead reading!
#Cardiology #AIHealth #Smartwatch #HeartDisease #MedTwitter #DigitalHealth #AHA25 #Wearables
16
💥 NEW CARDIOLOGY FINDING 💥
Personalized vitamin D3 supplementation tailored to optimal blood levels cuts second heart attack risk by ~50% in survivors! 🩺💊 This could change post-MI care forever.
#Cardiology #HeartAttack #VitaminD #HeartHealth #AHA25 #MedTwitter #PreventiveMed
32
🚨 BREAKTHROUGH: In high-risk patients without prior MI/stroke, adding evolocumab to statin therapy cut first major CV event risk by 25%! 💥
A landmark step in primary prevention for ASCVD & diabetics.
#Cardiology #PreventiveCardio #PCSK9 #Evolocumab #HeartHealth #LipidTherapy
17





























